Skip to main content

Table 2 Effects of SQ-LNS containing different amounts and sources of zinc provided along with malaria and diarrhea treatment on plasma zinc concentration and prevalence of low plasma zinc concentration in children at 9 and 18 months, by study group

From: Small-quantity lipid-based nutrient supplements containing different amounts of zinc along with diarrhea and malaria treatment increase iron and vitamin A status and reduce anemia prevalence, but do not affect zinc status in young Burkinabe children: a cluster-randomized trial

 

LNS-Zn0

LNS-Zn5

LNS-Zn10

LNS-TabZn5

P-value among 4 intervention groupsa,b

IC

NIC

P-value between cohortsa,b

ICCc

DEd

Plasma zinc concentration (μg/dL)e

 N (9 and 18 mo)

84

74

79

73

 

310

93

   

 Unadjusted pZC at 9 months

66.2 (63.4, 69.0)

66.0 (63.5, 68.6)

68.9 (66.5, 71.3)

68.8 (65.8, 72.0)

0.255

67.4 (66.1, 68.8)

65.1 (62.5, 67.7)

0.078

0.00

1.0

 Adjusted pZC at 9 months

68.0 (65.2, 70.9)

68.1 (65.6, 70.8)

71.0 (68.6, 73.5)

71.2 (68.1, 74.5)

0.212

69.5 (68.2, 70.9)

67.1 (64.5, 69.9)

0.090

0.00

1.0

 Unadjusted pZC at 18 months

61.7 (59.2, 64.4)

62.5 (60.1, 65.0)

64.4 (61.9, 67.0)

64.5 (62.4, 66.6)

0.774

63.2 (62.0, 64.4)

61.6 (59.4, 63.8)

0.968

0.02

1.3

 Adjusted pZC at 18 months

63.3 (60.7, 65.9)

64.2 (61.8, 66.7)

66.0 (63.5, 68.7)

65.9 (63.8, 68.1)

0.742

64.8 (63.6, 66.0)

63.6 (61.4, 65.8)

0.831

0.03

1.4

 Change in adjusted pZCf

−4.9 (−6.93, −2.78)

−4.0 (−6.58, −1.41)

−4.8 (−7.46, −2.13)

−6.0 (−8.89, −3.05)

0.843

−4.9 (−6.16, −3.64)

−3.9 (−6.23, −1.51)

0.391

% Low plasma zinc concentration (pZC <65 μg/dL)e

 Low unadjusted pZC at 9 months, N (%)

38 (45.3)

34 (45.9)

28 (35.4)

33 (45.2)

0.498

133 (42.9)

44 (47.3)

0.399

 Low adjusted pZC at 9 months, N (%)

29 (34.5)

28 (37.8)

22 (27.8)

27 (37.0)

0.587

106 (34.2)

36 (38.7)

0.370

 Low unadjusted pZC at 18 months, N (%)

53 (63.1)

46 (62.2)

46 (58.2)

39 (53.4)

0.909

184 (59.3)

56 (60.2)

0.379

 Low adjusted pZC at 18 months, N (%)

50 (59.5)

42 (56.8)

43 (54.4)

34 (46.6)

0.723

169 (54.5)

51 (54.8)

0.425

  1. pZC plasma zinc concentration
  2. aGeometric mean (95% confidence interval), n (%). Values in the same row with different superscript letters are significantly different (P < 0.05)
  3. bAdjusting for the random effect of the village and baseline value
  4. cInter-cluster coefficient calculated based on the cluster (village) variance and the residual variance from proc MIXED
  5. dDesign effect calculated based on the standard error of the intervention with or without the random effect of the cluster
  6. epZC adjusted for time of blood draw, time since last breastfeed and CRP and AGP concentration; and additionally for baseline value at 18 months
  7. fMeans (95% CI) were calculated based on non-transformed adjusted values, but covariance analysis was done with the logarithmic-transformed variable